Ronald S. Bauer

Statistics

Publications

Citations

386

H-Index

Active since

1959

Affiliations

United States Food and Drug Administration(Current)

Bristol-Myers Squibb (United States)

Health Canada

GlaxoSmithKline (United States)

Amgen (United States)

Ronald S. Bauer is an author at United States Food and Drug Administration specializing in pharmacy, bioanalytical method validation, and bioanalytical chemistry.

Publications per year

1959–2016

Publications

2012 White Paper on Recent Issues in Bioanalysis And Alignment of Multiple Guidelines

Binodh DeSilva, Fabio Garofolo, Mario L. Rocci et al. · Bioanalysis · 2012 · 101 citations

Pharmacy, Pharmaceutical Analysis, Analytical Toxicology +9

2011 White Paper on Recent Issues in Bioanalysis and Regulatory Findings from Audits and Inspections

Fabio Garofolo, Mario L. Rocci, Isabelle Dumont et al. · Bioanalysis · 2011 · 93 citations

Pharmacy, Chemistry, Pharmaceutical Analysis +15

2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV) (Part 1 – Small Molecules, Peptides and Small Molecule Biomarkers by LCMS)

Eric Yang, Jan Welink, Stephanie Cape et al. · Bioanalysis · 2016 · 48 citations · Full text

Pharmacy, Biochemistry, Biomedical Sciences +17

2014 White Paper on Recent Issues in Bioanalysis: A Full Immersion in Bioanalysis (Part 1 – Small Molecules by LCMS)

Eric Fluhler, Fabio Garofolo, Isabelle Dumont et al. · Bioanalysis · 2014 · 45 citations

Pharmacy, Medicinal Chemistry, Pharmaceutical Analysis +16

2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV): (Part 2 – Hybrid LBA/LCMS and Input from Regulatory Agencies)

An Song, Anita Lee, Fabio Garofolo et al. · Bioanalysis · 2016 · 43 citations · Full text

Pharmacy, Biomedical Sciences, Analytical Toxicology +16

1–5 of 8